CHINA China's nasal-spray COVID-19 vaccines undergoing clinical trials: official

CHINA

China's nasal-spray COVID-19 vaccines undergoing clinical trials: official

Xinhua

22:28, June 11, 2021

BEIJING, June 11 (Xinhua) -- Researchers are conducting phase-1 and phase-2 clinical trials on a China-made inhaled COVID-19 vaccine, a Chinese health official said Friday.

Photo: CGTN

After completing the collection of clinical-trial data, experts will study the safety and effectiveness of the inhaled vaccine, a modified version of an injectable adenovirus vector COVID-19 vaccine that has already hit the market, said Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, at a press conference.

The inhaled COVID-19 vaccine was jointly-developed by researchers from the Institute of Military Medicine under the Academy of Military Sciences and China's CanSino Biologics Inc.

Inhaled or nasal-spray vaccines were selected as one of China's vaccine technologies to combat COVID-19 from the very beginning, Shao added.

Another nasal-spray COVID-19 vaccine, developed by Xiamen University, the University of Hong Kong and Beijing Wantai Biological Pharmacy, has completed phase-1 and phase-2 trials. Researchers are applying phase-3 clinical trials overseas, to further evaluate the efficacy of the vaccine, according to Shao.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue